GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nanosonics Ltd (FRA:OQS) » Definitions » Revenue

Nanosonics (FRA:OQS) Revenue : €113.3 Mil (TTM As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Nanosonics Revenue?

Nanosonics's revenue for the six months ended in Dec. 2024 was €56.6 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2024 was €113.3 Mil. Nanosonics's Revenue per Share for the six months ended in Dec. 2024 was €0.18. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2024 was €0.37.

During the past 12 months, the average Revenue per Share Growth Rate of Nanosonics was 10.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 18.40% per year. During the past 5 years, the average Revenue per Share Growth Rate was 15.70% per year. During the past 10 years, the average Revenue per Share Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Nanosonics's highest 3-Year average Revenue per Share Growth Rate was 196.20% per year. The lowest was 11.80% per year. And the median was 23.00% per year.


Nanosonics Revenue Historical Data

The historical data trend for Nanosonics's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanosonics Revenue Chart

Nanosonics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 61.73 64.62 79.59 103.77 105.83

Nanosonics Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.96 53.24 48.88 56.70 56.61

Competitive Comparison of Nanosonics's Revenue

For the Medical Instruments & Supplies subindustry, Nanosonics's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosonics's Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nanosonics's Revenue distribution charts can be found below:

* The bar in red indicates where Nanosonics's Revenue falls into.



Nanosonics Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €113.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanosonics  (FRA:OQS) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Nanosonics Revenue Related Terms

Thank you for viewing the detailed overview of Nanosonics's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosonics Business Description

Traded in Other Exchanges
Address
7-11 Talavera Road, Level 1 Building A, Macquarie Park, Sydney, NSW, AUS, 2113
Nanosonics is a single-product firm and its Trophon device provides high-level disinfection of ultrasound probes used in semicritical procedures. The patented technology uses low-temperature sonically activated hydrogen peroxide mist suitable for probes sensitive to damage. Automated HLD is increasingly being used as the standard of care globally as it is superior in preventing cross-infection of patients. Nanosonics' revenue is made up of capital sales of Trophon units, ongoing consumables sales, and service revenue. By June 2022, there were 29,850 Trophon units installed globally. Market penetration rates range from over 75% in Australia and New Zealand, about 44% in the US to low-single-digit penetration in Europe, Middle East, and Africa, and elsewhere in the Asia-Pacific region.

Nanosonics Headlines

No Headlines